類器官
生物類器官、類器官分析及計算模型。連接研究原文、公司檔案與當前公開已核驗事件；保留來源和日期。
主題標籤來自自動檢索分類，用於找到相關材料；它不證明公司具有某項技術，也不等於研究已建立因果或臨床效果。
研究與行業原文
提速 60%：晶泰科技重磅论文揭示 AI+类器官如何重塑药物研发新范式
XtalPi official Chinese RSS · 行業原文收錄 · 來源發佈：Fri Sep 04 2026 01:29:23 GMT+0000 (Coordinated Universal Time) · 本站收錄：Mon Sep 14 2026 05:56:48 GMT+0000 (Coordinated Universal Time)
药物研发有一个绕不开的困境：早期实验表现再好的分子，到了人体身上也可能失败。 AI让“找到看起来不错的分子”这件事越来越快。但 验证的难题反而被进一步放大 ：我们能不能更早判断，它在真实疾病环境中是否真的有效？ 围绕这一难题，2026 年 8 月，晶泰科技与孵化企业希格生科在《中国药事》上联合发表了一篇论文《类器官+人工智能在药物研发中的应用探讨》。 论文背景是双方合作开发的弥漫性胃癌候选药物 SIGX1094，这是全球首款获得“医药界
Systematic scRNA-seq screens profile neural organoid response to morphogens.
Europe PMC REST API · 學術索引收錄 · 來源發佈：Mon Dec 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 09:08:13 GMT+0000 (Coordinated Universal Time)
Morphogens direct neuroepithelial fates toward discrete regional identities in vivo. Neural organoids provide models for studying neural regionalization through morphogen exposure; however, we lack a comprehensive survey
Cell tracking with accurate error prediction.
Europe PMC REST API · 學術索引收錄 · 來源發佈：Wed Oct 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 06:39:04 GMT+0000 (Coordinated Universal Time)
Cell tracking is an indispensable tool for studying development by time-lapse imaging. However, existing cell trackers cannot assign confidence to predicted tracks, which prohibits fully automated analysis without manual
Digitalized organoids: integrated pipeline for high-speed 3D analysis of organoid structures using multilevel segmentation and cellular topology.
Europe PMC REST API · 學術索引收錄 · 來源發佈：Wed May 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 06:43:58 GMT+0000 (Coordinated Universal Time)
Organoids replicate tissue architecture and function and offer a unique opportunity to explore the impact of external perturbations in vitro. However, conducting large-scale screening procedures to investigate the effect
The Life Science business of Merck KGaA, Darmstadt, Germany Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio
HUB Organoids official news RSS · 行業原文收錄 · 來源發佈：Mon Jan 06 2025 13:23:34 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
Reinforces company’s commitment to differentiated solutions that enable faster and more effective drug development HUB’s organoid offering complements company’s cell culture portfolio of media, reagents, and benchtop ins
The Life Science business of Merck KGaA, Darmstadt, Germany, to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio
HUB Organoids official news RSS · 行業原文收錄 · 來源發佈：Tue Dec 17 2024 14:05:21 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
HUB internationally recognized pioneer in organoid development Acquisition expands Merck’s 2D and 3D cell culture portfolio Organoids part of fastest growing cell culture segment; hold potential to speed up drug developm
HUB Organoids B.V. Awarded Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Transforming Drug Development with Highly Advanced Organoid Technology
HUB Organoids official news RSS · 行業原文收錄 · 來源發佈：Tue May 14 2024 12:51:39 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
HUB Organoids B.V. revolutionizes preclinical and clinical drug development through its cutting-edge organoid technology, enhancing its accuracy and efficiency. San Antonio, TX — May 14 2024 — Frost & Sullivan recently r
HUB Organoids Launches IntegriGut Screen: A Breakthrough Service Offering for Inflammatory Bowel Disease (IBD) Drug Discovery and Development
HUB Organoids official news RSS · 行業原文收錄 · 來源發佈：Wed Jan 24 2024 17:36:01 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
Utrecht, Netherlands – 25th Jan 2024 – HUB Organoids (HUB), a global leader and sole proprietor of patient-derived organoid technology for drug discovery and development, today announced the global launch of its new Inte
Tumors in Space Investigates Microgravity’s Impact on Cancer Using Patient-Derived HUB Organoids
HUB Organoids official news RSS · 行業原文收錄 · 來源發佈：Thu Nov 30 2023 09:42:03 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
Utrecht, November 30, 2023 – HUB Organoids B.V. participates in the second Tumors in Space European Space Agency parabolic flight which investigates the effect of microgravity on gene expression to identify potential tar
HUB Organoids Announces New Corporate Strategy and Completes Transition from Foundation to Private Company
HUB Organoids official news RSS · 行業原文收錄 · 來源發佈：Tue Jul 18 2023 01:00:54 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
[Utrecht, July 18 2023] — HUB Organoids (HUB), the global leader in the field of patient-derived organoids, is excited to announce a significant milestone in its evolution. After years of successful operations as a found
HUB Organoids extends partnership with Molecular Devices to advance automated intestinal organoid screening technology
HUB Organoids official news RSS · 行業原文收錄 · 來源發佈：Sat Mar 04 2023 13:34:09 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
SAN JOSE, Calif., and UTRECHT, Netherlands, Feb. 13, 2023 – Molecular Devices, LLC., a leading provider of high-performance life science solutions, and HUB Organoids (HUB), the pioneer in the field of adult stem cell-der
HUB Organoids take their first parabolic flight!
HUB Organoids official news RSS · 行業原文收錄 · 來源發佈：Sat Mar 04 2023 13:32:53 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
The post HUB Organoids take their first parabolic flight! appeared first on HUB Organoids .
當前公開已核驗事件
當前沒有符合條件的公開已核驗事件。
有相關公開原文的公司
- 晶泰科技 · AI與模型數據 · 中国/美国
專題指南：從原文到判斷
按任務比較模型，按證據追蹤合作；每篇保留原始出處與更新日期。